Lorenza Putignani is an expert in Infectiology at Bambino Gesù Children's Hospital (Italy). Lorenza Putignani has authored 281 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 904 (community average: 125). How the SLR is computed.

LeadR Profile

Lorenza Putignani Bambino Gesù Children's Hospital Italy
904 ScienceLeadR Reputation 904
Network Map

Infectiology

Subspecialties: Biochemistry - Nutrition - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026

Source: PubMed

Ospedale Pediatrico Bambino Gesù

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 281

Citations

Citations: 11 277 1st author: 24 Last author: 84 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rethinking Solid-Phase Microextraction (SPME) for Bioanalysis: Workflow Optimisation in Automated Vacuum-Assisted Cooling SPME for Fatty Acid Monitoring in Faecal Waters.
PMID 42943785 — workflow, vacuum, fatty acids
Molecules20260
Host-Microbiota Interactions in Adolescents with Severe Anorexia Nervosa: Linking Gut Dysbiosis, Intestinal Barrier Function and Microbial Metabolism.
PMID 42884588 — dysbiosis, anorexia, rehabilitation, biomarkers, food, adolescent, host microbial interactions, gastrointestinal microbiome, anorexia nervosa, microbiota
Nutrients20260
Ecological Patterns of Gut Microbiota During Elexacaftor/Tezacaftor/Ivacaftor Therapy in Cystic Fibrosis.
PMID 42795633 — genes, fibrosis, cystic fibrosis, therapeutics, gastrointestinal microbiome, microbiota
Microorganisms20260
Integrated Multi-Omics Reveals Complementary Luminal and Mucosal Host-Microbiome Interactions Associated with Disease Activity and Phenotype in Paediatric Inflammatory Bowel Disease.
PMID 42795608 — mycobiome, phenotype, multiple chronic conditions, biomarkers, inflammatory bowel diseases, metabolomics, gastrointestinal microbiome
Microorganisms20260
Microbial Natural Products Targeting the Mycobacterium tuberculosis Complex: Toward the Discovery of Novel Anti-Tubercular Agents.
PMID 42795515 — mycobacterium, pharmaceutical preparations, tuberculosis, mycobacterium tuberculosis
Microorganisms20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map